Questions & Answers

Find out the common answers to frequently asked questions regarding the COG-Train programme

1. What is COG-Train?

COG-Train is an educational initiative developed jointly by the COVID-19 Genomics UK (COG-UK) consortium and Wellcome Connecting Science (WCS) to provide open-access learning in SARS-CoV-2 genomics. For details about the COG-Train programme, please click here.

2. What resources will COG-Train create?

COG-Train will create a series of open-access courses covering multiple aspects of SARS-CoV-2 sequencing. These courses will be based upon WCS’s prior successful use of the FutureLearn platform, and will cover topics such as: analysis, data linkage, and integration with public health and policy bodies.

The COG-Train programme will also include virtual courses featuring a week of live training delivered online. These courses will include train-the-trainer components developed in partnership with Wellcome Africa and Asia programmes (AAPs) and aim to support trainees in both learning new technology and developing their pedagogical skills. A remote classroom model will be used to increase the reach and impact of COG-Train learning materials, with training being delivered simultaneously in many classrooms across multiple countries.

Initial COG-Train web resources will be available later this year with delivery of the first online courses by end of 2021. If you would like to be notified when resources become available, please contact COG-Train@medschl.cam.ac.uk.

3. Who are COG-Train’s resources for?

Whilst anyone is welcome to participate in COG-Train’s open-access courses, the programme’s efforts are primarily focused on supporting the dissemination of SARS-CoV-2 sequencing knowledge to low- and middle- income countries, where the need for further training is at its greatest.

4. Can COG-Train offer genomic surveillance support?

COG-Train is not able to offer one-to-one training or single-country assistance with genomic surveillance at this time. If you require genomics surveillance support, we would like to direct you to the New Variant Assessment Programme (NVAP), set up by the UK government to assist other countries in their response to COVID-19.  We hope that this programme will be able to support your sequencing needs.